{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T19:30:37Z","timestamp":1776713437158,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.bbrc.2013.10.076","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T17:36:02Z","timestamp":1383240962000},"page":"668-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Berberine slows cell growth in autosomal dominant polycystic kidney disease cells"],"prefix":"10.1016","volume":"441","author":[{"given":"Anna","family":"Bonon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Mangolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Pinton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9392-7021","authenticated-orcid":false,"given":"Laura","family":"del Senno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-0805","authenticated-orcid":false,"given":"Gianluca","family":"Aguiari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2013.10.076_b0005","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM199307293290508","article-title":"Autosomal dominant polycystic kidney disease","volume":"329","author":"Gabow","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2013.10.076_b0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbrc.2013.10.076_b0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1067\/mlc.2003.13","article-title":"Autosomal dominant kidney disease: molecular genetics and pathophysiology","volume":"141","author":"Sutters","year":"2003","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.bbrc.2013.10.076_b0020","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein","volume":"272","author":"Mochizuki","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2013.10.076_b0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ncb754","article-title":"Polycystin-2 is an intracellular calcium release channel","volume":"4","author":"Koulen","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2013.10.076_b0030","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0006-291X(02)03011-5","article-title":"Expression of polycystin-1 C-terminal fragment enhances the ATP-induced Ca2+ release in human kidney cells","volume":"301","author":"Aguiari","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2013.10.076_b0035","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1096\/fj.03-0687fje","article-title":"Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells","volume":"18","author":"Aguiari","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2013.10.076_b0040","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-2184.2008.00529.x","article-title":"Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells","volume":"41","author":"Aguiari","year":"2008","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bbrc.2013.10.076_b0045","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2013.10.076_b0050","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbadis.2009.03.001","article-title":"Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells","volume":"1792","author":"Aguiari","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2013.10.076_b0055","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2013.10.076_b0060","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/j.1523-1755.2004.00667.x","article-title":"A plethora of epidermal growth factor-like proteins in polycystic kidneys","volume":"65","author":"Wilson","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2013.10.076_b0065","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00109-012-0902-3","article-title":"Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation","volume":"90","author":"Aguiari","year":"2012","journal-title":"J. Mol. Med."},{"issue":"367","key":"10.1016\/j.bbrc.2013.10.076_b0070","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"The TEMPO 3: 4 trial investigators: tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"20","author":"Torres","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2013.10.076_b0075","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2013.10.076_b0080","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2013.10.076_b0085","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1046\/j.1523-1755.2003.00256.x","article-title":"EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han: SPRD rats","volume":"64","author":"Torres","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2013.10.076_b0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000346812","article-title":"Multidrug therapy for polycystic kidney disease: a review and perspective","volume":"37","author":"Aguiari","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.bbrc.2013.10.076_b0095","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.10.076_b0100","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1681\/ASN.2005060645","article-title":"Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells","volume":"17","author":"Yamaguchi","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2013.10.076_b0105","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0700499104","article-title":"Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease","volume":"104","author":"Leuenroth","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2013.10.076_b0110","doi-asserted-by":"crossref","first-page":"F397","DOI":"10.1152\/ajprenal.00310.2002","article-title":"Immortalized epithelial cells from human autosomal polycystic kidney cysts","volume":"285","author":"Loghman-Adham","year":"2003","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bbrc.2013.10.076_b0115","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1242\/jcs.02818","article-title":"Polycystin-2 traffics to cilia independently of polycystin-1 by using an N-terminal RVxP motif","volume":"119","author":"Geng","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbrc.2013.10.076_b0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.yexcr.2004.10.023","article-title":"The cytoplasmic C-terminus of polycystin-1 increases cell proliferation in kidney epithelial cells through serum-activated and Ca(2+)-dependent pathway(s)","volume":"304","author":"Manzati","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2013.10.076_b0125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/excr.1998.4198","article-title":"K562 erythroid and HL60 macrophage differentiation downregulates polycystin, a large membrane-associated protein","volume":"244","author":"Aguiari","year":"1998","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2013.10.076_b0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bcp.2011.11.008","article-title":"Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression","volume":"83","author":"Kim","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2013.10.076_b0135","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1523-1755.1999.00370.x","article-title":"New insights into the molecular pathophysiology of polycystic kidney disease","volume":"55","author":"Murcia","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2013.10.076_b0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0304-3835(99)00264-5","article-title":"Inhibitory effect of coptidis rhizoma and berberine on the proliferation of human esophageal cancer cell lines","volume":"148","author":"Iizuka","year":"2000","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2013.10.076_b0145","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/MCB.01259-08","article-title":"Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1","volume":"29","author":"Distefano","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2013.10.076_b0150","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.mehy.2009.05.043","article-title":"Activation of AMP-activated kinase as a strategy for managing autosomal dominant polycystic kidney disease","volume":"73","author":"McCarty","year":"2009","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bbrc.2013.10.076_b0155","first-page":"4063","article-title":"Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells","volume":"29","author":"Ho","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2013.10.076_b0160","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jep.2010.01.047","article-title":"Identification of the toxic constituents in Rhizoma Coptidis","volume":"128","author":"Ma","year":"2010","journal-title":"J. Ethnopharmacol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13017579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13017579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T17:13:08Z","timestamp":1564593188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X13017579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0006291X13017579"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.10.076","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberine slows cell growth in autosomal dominant polycystic kidney disease cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.10.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}